In addition to SOX9, THY-1, CD3D, IL13, HSPA6, and MMP7 demonstrated the best performance in detecting fast-progressor NAFLD patients with F1/F2. The gene discussed is CD3D; the disease is metabolic dysfunction-associated steatotic liver disease.